1. Home
  2. VIAV vs BIO Comparison

VIAV vs BIO Comparison

Compare VIAV & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

N/A

Current Price

$30.87

Market Cap

9.0B

Sector

Technology

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$366.78

Market Cap

10.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
VIAV
BIO
Founded
1923
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
10.3B
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
VIAV
BIO
Price
$30.87
$366.78
Analyst Decision
Strong Buy
Hold
Analyst Count
8
3
Target Price
$56.00
★ $356.67
AVG Volume (30 Days)
★ 6.5M
234.8K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 142.61
EPS
0.29
★ 11.25
Revenue
$1,518,300,000.00
★ $2,583,200,000.00
Revenue This Year
$34.44
N/A
Revenue Next Year
$14.47
$1.86
P/E Ratio
$112.17
★ $32.84
Revenue Growth
★ 40.03
0.65
52 Week Low
$15.51
$236.73
52 Week High
$60.43
$396.23

Technical Indicators

Market Signals
Indicator
VIAV
BIO
Relative Strength Index (RSI) 44.72 45.98
Support Level $25.73 $354.27
Resistance Level $36.85 $391.44
Average True Range (ATR) 2.45 13.26
MACD 0.39 -0.39
Stochastic Oscillator 64.07 35.93

Price Performance

Historical Comparison
VIAV
BIO

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc is a world-wide leader in test and measurement and optical technologies. Its test and measurement, and resilient Position, Navigation and Timing (PNT) solutions enable and secure critical infrastructure ranging from data center ecosystems and communication networks to military, aerospace, railway and first responder communications. In addition, it develop and advance technologies used in high-volume optical applications across anti-counterfeiting, consumer electronics, aerospace, industrial and automotive end markets. The company's segments are Network and Service Enablement (NSE); and Optical Security and Performance Products (OSP). Majority of revenue comes from NSE segment. It has presence in Americas, Asia-Pacific, and EMEA. Majority of revenue is from America.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: